Skip to main content

Day: May 9, 2022

Kvika banki hf.: Publication of Q1 financial statement and investor presentation on Thursday 12 May

The board of directors of Kvika banki hf. is set to approve the financial statements of the Group for Q1 2022 at a board meeting on Thursday 12 May. The financial statements will subsequently be published after domestic markets have closed. A meeting for shareholders and market participants will be held the same day, at 16:15 GMT on Thursday 12 May, at the bank’s headquarters on the 9th floor at Katrínartún 2, 105 Reykjavík where the financial results will be presented. The presentation will be conducted in Icelandic and will be streamed live. Further, a recording of the meeting with English subtitles will later be made available on Kvika’s website. Meeting participants will be able to send questions before or during the meeting to the email fjarfestatengsl@kvika.is. The investor presentation will be made public before the meeti...

Continue reading

Tejon Ranch Co. Announces First Quarter 2022 Financial Results

TEJON RANCH, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three-months ended March 31, 2022. “The momentum we created at our commerce center continues with the formation of another joint-venture with Majestic Realty Co., to construct an approximately 446,400 square foot industrial building within our ever-growing distribution hub located in Tejon Ranch Commerce Center (TRCC),” said Gregory S. Bielli, President and CEO of Tejon Ranch. “With the sale of a 12.3-acre land parcel in the first quarter to Dedeaux Properties, all of the land on the west side of TRCC is now fully absorbed. We plan to continue to build off this momentum as we work to complete our design efforts for the multi-family...

Continue reading

CORRECTING AND REPLACING — Amicus Therapeutics Announces First Quarter 2022 Financial Results

1Q22 Galafold® Revenue Growth of 18.5% to $78.7M New Composition of Matter Patent for Galafold® Strengthens U.S. Patent Protection into 2038 Advancing U.S. and EU Regulatory Reviews and Launch Preparations for AT-GAA in Pompe Disease Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease Presented at 2022 MDA Conference Conference Call and Webcast Today at 8:30 a.m. ET PHILADELPHIA, May 09, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Amicus Therapeutics, Inc., (Nasdaq: FOLD) please note that in the third bullet under the First Quarter 2022 Financial Results section, the Total GAAP operating expenses should be $146.5 million, not $147.1 million as previously stated. The corrected release follows: Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology...

Continue reading

Vestjysk Bank’s Q1 2022 Quarterly Report

Nasdaq Copenhagen A/S 9 May 2022Highlights for Q1 2022 For Q1 2022, Vestjysk Bank reported an acceptable profit before tax of DKK 99m. Net interest and fee income is reported at DKK 369, which is satisfactorily and DKK 39m better than the same period last year, where the net interest and fee income was DKK 330m. The financial performance was affected by the increasing interest rate level in the market. The increasing interest rates had a negative impact on the market value of the Bank’s own portfolio of bonds, and price adjustments affected profit adversely by DKK 58m. The Bank’s write-downs for the period were not significantly affected by the aftermath of the Corona pandemic, Brexit or the risk of further spread of African swine fever. The same applies in relation to the current situation of the war in Ukraine. The Bank continues...

Continue reading

Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the first quarter ended March 31, 2022. “In the first quarter, we regained the rights to CB 2782-PEG, a C3 degrader protease, for the potential treatment of dry age-related macular degeneration (“AMD”) and now have full rights to two wholly-owned, potential best-in-class complement candidates that may provide compelling opportunities in our exploration of strategic alternatives as announced in February,” said Nassim Usman, Ph.D., president and chief executive officer of Catalyst. “While exploring these opportunities, we implemented personnel and cost reductions, decreasing our headcount by over 70%. We remain committed to exploiting the potential for all of our assets to...

Continue reading

Global Innovation Leader Rush Doshi Joins as Advisor to DriveItAway Holdings, Inc (OTC: CLCN)

Former Entrepreneur in Residence of EmployBridge & Citi to advise DriveItAway in Providing Employer ESG/EV Focused Entry Level Employee Transportation Solutions “Lack of transportation in the single largest impediment to entry level employee success, we are thrilled to have Rush Doshi help us reach out to large national employers to solve this problem,” John F. Possumato, CEO, DriveItAway Holdings Inc. PHILADELPHIA, May 09, 2022 (GLOBE NEWSWIRE) — DriveItAway Holdings, Inc. (“DIA”) OTCQB: CLCN) the industry leader in automotive dealer new mobility platforms, with its revolutionary subscription to purchase technology, announces today that Rushab Doshi, noted entrepreneur-in-residence and new venture builder, has joined the newly public DriveItAway team as an advisor to their continued expansion in its program for large employers...

Continue reading

BOS Purchases Warehouses and Office Space for Self-use

RISHON LE ZION, Israel, May 09, 2022 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) announced today that it has purchased 546 sqm of offices, 495 sqm of warehouses and nine parking spots in Rishon Le Zion, Israel. The purchased real-estate is part of the facilities BOS has been leasing in Rishon Lezion. BOS shall pay for this acquisition NIS 6.5 million (approximately $1.9 million). Eyal Cohen, BOS’ CEO, stated: “BOS leases 2,131 sqm in Rishon Lezion and 710 sqm in Rosh Hain, both in Israel. Our monthly lease expense for the facilities we acquired amounts to $10,000. This lease expense, and our expectation that it shall increase significantly upon lease renewal, led us to pursue the acquisition. “We plan to finance the purchase by a long-term bank loan in...

Continue reading

Nokia launches groundbreaking cybersecurity-focused testing lab in the U.S.

Press Release Nokia launches groundbreaking cybersecurity-focused testing lab in the U.S.First U.S.-based end-to-end cybersecurity 5G testing lab opens in Dallas Both Nokia products and partner products will be tested against real-world attack scenarios09 May 2022 Dallas, Texas – Nokia today announced the launch of its Advanced Security Testing and Research (ASTaR) lab, located in Dallas, Texas. It is the first end-to-end 5G testing lab in the U.S. focused solely on cybersecurity. ASTaR’s holistic approach to researching and testing secure solutions and potential network threat mitigations will go beyond looking at individual network elements and also focus on the larger context of network use and abuse scenarios. In the 5G era, the nature and scale of information networks are evolving, as are the nature and scale of security threats....

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – SHAFTESBURY PLC – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – CAPITAL & COUNTIES PROPERTIE – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.